Labcorp Holdings Net Profit Margin 2010-2025 | LH
Current and historical net profit margin for Labcorp Holdings (LH) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Labcorp Holdings net profit margin for the three months ending June 30, 2025 was .
| Labcorp Holdings Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2025-06-30 | $13.48B | $0.76B | 5.66% |
| 2025-03-31 | $13.18B | $0.73B | 5.54% |
| 2024-12-31 | $13.01B | $0.75B | 5.73% |
| 2024-09-30 | $12.71B | $0.44B | 3.42% |
| 2024-06-30 | $12.49B | $0.45B | 3.60% |
| 2024-03-31 | $12.30B | $0.43B | 3.52% |
| 2023-12-31 | $12.16B | $0.42B | 3.44% |
| 2023-09-30 | $11.30B | $0.66B | 5.85% |
| 2023-06-30 | $11.11B | $0.83B | 7.48% |
| 2023-03-31 | $11.00B | $1.00B | 9.10% |
| 2022-12-31 | $11.87B | $1.28B | 10.79% |
| 2022-09-30 | $10.76B | $1.76B | 16.33% |
| 2022-06-30 | $11.96B | $1.99B | 16.65% |
| 2022-03-31 | $12.88B | $2.10B | 16.30% |
| 2021-12-31 | $13.14B | $2.38B | 18.09% |
| 2021-09-30 | $16.56B | $2.76B | 16.68% |
| 2021-06-30 | $16.39B | $2.88B | 17.56% |
| 2021-03-31 | $15.32B | $2.64B | 17.26% |
| 2020-12-31 | $13.98B | $1.56B | 11.13% |
| 2020-09-30 | $12.44B | $0.85B | 6.79% |
| 2020-06-30 | $11.48B | $0.36B | 3.16% |
| 2020-03-31 | $11.59B | $0.32B | 2.77% |
| 2019-12-31 | $11.56B | $0.82B | 7.13% |
| 2019-09-30 | $11.39B | $0.76B | 6.63% |
| 2019-06-30 | $11.29B | $0.85B | 7.55% |
| 2019-03-31 | $11.28B | $0.90B | 7.95% |
| 2018-12-31 | $11.33B | $0.88B | 7.80% |
| 2018-09-30 | $11.29B | $1.41B | 12.52% |
| 2018-06-30 | $11.08B | $1.27B | 11.44% |
| 2018-03-31 | $10.74B | $1.22B | 11.34% |
| 2017-12-31 | $10.31B | $1.23B | 11.91% |
| 2017-09-30 | $9.90B | $0.70B | 7.11% |
| 2017-06-30 | $9.70B | $0.71B | 7.34% |
| 2017-03-31 | $9.60B | $0.73B | 7.61% |
| 2016-12-31 | $9.55B | $0.71B | 7.45% |
| 2016-09-30 | $9.52B | $0.66B | 6.92% |
| 2016-06-30 | $9.42B | $0.63B | 6.72% |
| 2016-03-31 | $9.26B | $0.60B | 6.47% |
| 2015-12-31 | $8.68B | $0.44B | 5.05% |
| 2015-09-30 | $7.89B | $0.45B | 5.68% |
| 2015-06-30 | $7.13B | $0.43B | 6.03% |
| 2015-03-31 | $6.37B | $0.40B | 6.29% |
| 2014-12-31 | $6.01B | $0.51B | 8.50% |
| 2014-09-30 | $5.94B | $0.52B | 8.71% |
| 2014-06-30 | $5.85B | $0.53B | 9.03% |
| 2014-03-31 | $5.80B | $0.54B | 9.30% |
| 2013-12-31 | $5.81B | $0.57B | 9.87% |
| 2013-09-30 | $5.78B | $0.57B | 9.82% |
| 2013-06-30 | $5.73B | $0.57B | 9.89% |
| 2013-03-31 | $5.69B | $0.57B | 9.99% |
| 2012-12-31 | $5.67B | $0.58B | 10.28% |
| 2012-09-30 | $5.63B | $0.60B | 10.62% |
| 2012-06-30 | $5.62B | $0.58B | 10.40% |
| 2012-03-31 | $5.60B | $0.55B | 9.90% |
| 2011-12-31 | $5.54B | $0.52B | 9.36% |
| 2011-09-30 | $5.47B | $0.52B | 9.43% |
| 2011-06-30 | $5.34B | $0.52B | 9.77% |
| 2011-03-31 | $5.18B | $0.55B | 10.68% |
| 2010-12-31 | $5.00B | $0.56B | 11.17% |
| 2010-09-30 | $4.87B | $0.57B | 11.69% |
| 2010-06-30 | $4.78B | $0.56B | 11.73% |
| 2010-03-31 | $4.73B | $0.54B | 11.47% |
| 2009-12-31 | $4.70B | $0.54B | 11.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $23.101B | $13.009B |
| Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| DiDi Global (DIDIY) | China | $27.533B | 22.50 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| ICON (ICLR) | Ireland | $14.370B | 13.83 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.08 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Teladoc Health (TDOC) | United States | $1.366B | 0.00 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |